Targeting KRASG12C in Solid Tumors: A New Anticancer Approach

Download All
Learn about a new anticancer strategy that targets KRASG12C in solid tumors in this expert-authored online activity with downloadable slides.
Marwan Fakih, MD

Module

Explore new anticancer strategies targeting KRASG12C in solid tumors in this expert-authored online activity with downloadable slides.

Marwan Fakih, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: October 29, 2020 Expired: No longer available for credit

In this downloadable slideset, Marwan Fakih, MD, reviews key concepts and the latest clinical trial data on targeting KRASG12C for the treatment of solid tumors.

Marwan Fakih, MD Released: October 29, 2020
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Amgen

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings